Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2006; Volume 186, Supplement 650
Joint Meeting of The German Society of Physiology and The Federation of European Physiological Societies 2006
3/26/2006-3/29/2006
Ludwig-Maximilians-University, Munich


EFFECT OF PHENYLALKYLAMINES AND BENZOTHIAZEPINES ON CAV1.3 CALCIUM CURRENTS IN MOUSE INNER HAIR CELLS.
Abstract number: PW07A-3

Tarabova1,2 B, Lacinova1,2 L, Engel1,2 J

1Institute of Molecular Physiology and Genetics SAS
2University of Tbingen, Institute of Physiology II and Department of Otorhinolaryngology, THRC, Tbingen, Germany

Calcium currents in mouse inner hair cells (IHC) are carried predominantly by the Cav1.3 subtype of L-type voltage gated calcium channels. They differ from Cav1.2 channels in many aspects including differential pharmacological properties. We investigated the effect of phenylalkylamine (PAA) verapamil and benzothiazepines (BTZ) diltiazem and gallopamil on the Ca2+ currents in mouse IHCs. We recorded calcium currents of IHCs in acute preparations of the organ of Corti (age: P3-P7) by using the whole-cell configuration of the patch-clamp method with 5 mM Ca2+ as charge carrier. Both PAA and BTZs inhibited about 90 % of the current at the concentration of 3 mM. This effect was largely reversible. For verapamil, IC50 was 199 ± 19 mM and the Hill coefficient was 0.64 ± 0.02. For diltiazem IC50 was 334 ± 52 mM and for gallopamil 467 ± 151 mM. Corresponding Hill coefficients were 0.98 ± 0.12 and 0.84 ± 0.20, respectively.

These concentrations were similar to those needed to block recombinant Cav1.2 channels (Lacinova et al., J. Pharmacol. Exp. Ther. 1995) or L-type, supposedly Cav1.3 Ca2+ channels in turtle hair cells (Schnee and Ricci, J. Physiol. 2003). Supported by the EU Marie-Curie Trainings Site programme.

To cite this abstract, please use the following information:
Acta Physiologica 2006; Volume 186, Supplement 650 :PW07A-3

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE